HeXun Biosciences Co Ltd (6986) Stock Statistics & Valuation Metrics
Total Valuation
HeXun Biosciences Co Ltd has a market cap or net worth of TWD 2.09B. The enterprise value is TWD 2.16B.
- Market Cap
- TWD 2.09B
- Enterprise Value
- TWD 2.16B
Share Statistics
HeXun Biosciences Co Ltd has 52,134,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 52,134,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
HeXun Biosciences Co Ltd’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 13.47%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.13
- Return on Invested Capital (ROIC)
- 13.47%
- Return on Capital Employed (ROCE)
- 0.15
- Revenue Per Employee
- 5.53M
- Profits Per Employee
- 2.11M
- Employee Count
- 53
- Asset Turnover
- 0.35
- Inventory Turnover
- 7.99
Valuation Ratios
The current PE Ratio of HeXun Biosciences Co Ltd is 15.48. HeXun Biosciences Co Ltd’s PEG ratio is -0.51.
- PE Ratio
- 15.48
- PS Ratio
- 6.60
- PB Ratio
- 1.70
- Price to FCF
- 15.29
- Price to Operating Cash Flow
- 11.07
- PEG Ratio
- -0.51
Income Statement
In the last 12 months, HeXun Biosciences Co Ltd had revenue of 293.23M and earned 111.91M in profits. Earnings per share was 2.43.
- Revenue
- 293.23M
- Gross Profit
- 245.15M
- Operating Income
- 118.00M
- Pretax Income
- 125.93M
- Net Income
- 111.91M
- EBITDA
- 146.95M
- Earnings Per Share (EPS)
- 2.43
Cash Flow
In the last 12 months, operating cash flow was 163.75M and capital expenditures -30.73M, giving a free cash flow of 133.02M billion.
- Operating Cash Flow
- 163.75M
- Free Cash Flow
- 133.02M
- Free Cash Flow per Share
- 2.86
Dividends & Yields
HeXun Biosciences Co Ltd pays an annual dividend of ―, resulting in a dividend yield of 0.48%
- Dividend Per Share
- ―
- Dividend Yield
- 0.48%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.54%
- Earnings Yield
- 6.42%
Stock Price Statistics
- Beta
- 0.25
- 52-Week Price Change
- -24.91%
- 50-Day Moving Average
- 43.10
- 200-Day Moving Average
- 51.66
- Relative Strength Index (RSI)
- 21.80
- Average Volume (3m)
- 65.41K
Important Dates
HeXun Biosciences Co Ltd upcoming earnings date is Mar 12, 2027, TBA (Not Confirmed).
- Last Earnings Date
- May 15, 2026
- Next Earnings Date
- Mar 12, 2027
- Ex-Dividend Date
- ―
Financial Position
HeXun Biosciences Co Ltd as a current ratio of 9.75, with Debt / Equity ratio of 4.93%
- Current Ratio
- 9.75
- Quick Ratio
- 9.65
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.17
- Interest Coverage Ratio
- 105.93
Taxes
In the past 12 months, HeXun Biosciences Co Ltd has paid 14.02M in taxes.
- Income Tax
- 14.02M
- Effective Tax Rate
- 0.11
Enterprise Valuation
HeXun Biosciences Co Ltd EV to EBITDA ratio is 10.06, with an EV/FCF ratio of 12.41.
- EV to Sales
- 5.35
- EV to EBITDA
- 10.06
- EV to Free Cash Flow
- 12.41
- EV to Operating Cash Flow
- 10.08
Balance Sheet
HeXun Biosciences Co Ltd has TWD 828.93M in cash and marketable securities with TWD 34.66M in debt, giving a net cash position of TWD 794.26M billion.
- Cash & Marketable Securities
- TWD 828.93M
- Total Debt
- TWD 34.66M
- Net Cash
- TWD 794.26M
- Net Cash Per Share
- TWD 15.24
- Tangible Book Value Per Share
- TWD 22.62
Margins
Gross margin is 85.60%, with operating margin of 42.36%, and net profit margin of 37.74%.
- Gross Margin
- 85.60%
- Operating Margin
- 42.36%
- Pretax Margin
- 45.82%
- Net Profit Margin
- 37.74%
- EBITDA Margin
- 53.22%
- EBIT Margin
- 43.48%
